Does the Negativation of the Glucose Hydrogen Breath Test Come Along With a Reduction of the Symptoms of Gaz Incontinence ?
NCT ID: NCT01275560
Last Updated: 2015-06-03
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
PHASE3
16 participants
INTERVENTIONAL
2011-01-31
2015-06-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Fecal Incontinence and Rectal Static Disorder
NCT04566640
Safety and Tolerability of the Twice Daily Intra-anal Application of NRL001 Cream for 14 Days
NCT06593730
Normal Values in Ano-rectal 3D High Resolution Manometry
NCT01710579
Evaluation of Glycerin Suppositories to Improve Bowel Function in Gastroschisis
NCT03355326
Treatment of Fecal Incontinence After Obstetric Anal Sphincter Injuries
NCT01528995
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Metronidazole
3 intakes per day during 10 days
Metronidazole
Metronidazole,per os,500mg, 3 per day during 10 days
Carbosylane
3 intakes per daysduring 10 days
CArbosylane
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Metronidazole
Metronidazole,per os,500mg, 3 per day during 10 days
CArbosylane
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Afflilied to national health security
* Having read and sign the information letter and consent form
Exclusion Criteria
* use of antibiotics, probiotics, IPP for less tha n 3 months
* past of small intestinal bacterial overgrowth
* ischemic, inflammatory colitis,colo-rectal cancer
* diabetes
* allergy to metronidazole
* psychiatric disease
* patients who do not speak or read french
18 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
University Hospital, Rouen
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Physiology Unit, Hopital Charles Nicolle, 1 rue de Germont
Rouen, , France
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
2008/073/HP
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.